Karen Appold

Some of the usual suspects are on the list. And population health itself is trending as a competitive business and an area of study.

Screening and some care have been canceled or deferred. Will more illness and deaths result?

Adjustments to payment models are beginning to take social determinants into account.

Insight into people’s irrational choices can improve healthcare.

Some see the decline in healthcare utilization as an opportunity to eliminate ineffective, sometimes harmful healthcare.

Many of the large insurers are responding by expanding into new markets.

Applying lessons from behavioral economics, health systems are using “nudges” to influence the choices clinicians make.

Two newly approved antibody-drug conjugates and changes in radiation therapy lead the way.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a Q&A interview between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

What does it mean? When did it begin? How is it different from public health? Here are the answers to these questions and more.

Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Managed Healthcare Executive's October issue headlines 10 chosen healthcare leaders in its fourth annual "10 Emerging Industry Leaders" feature. MHE spotlights each leader individually with a video interview to accompany the Q&A between MHE and the emerging leader.

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

Health and healthcare inequities are the most likely explanation for the disproportionate effect.

Managed Healthcare Executive® interviewed six healthcare executives about how they and their organizations have responded to the outbreak.

There is fairly broad agreement that conditions like cancer, diabetes, and more will be the most costly for the American healthcare system over the next decade.

Here’s a look at what payers and providers can expect to occur, why each change is occurring, and how payers and providers can prepare for each change.

Here are healthcare leaders’ top challenges, as well as coping strategies

New administrative technology, treatment enhancements, and more.

Cancer care enters a new, exciting phase, experts say.

They’re a huge part of healthcare spending-but administrative costs don’t have to be so high.

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.

Experts provide 14 ways that insurers can improve their members’ experiences with them.